Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management
Fang Fang, Hongwei Sun, Zuowei Wang, et al.
CNS Drugs (2016) Vol. 30, Iss. 9, pp. 845-867
Closed Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Sleep disturbance and psychiatric disorders
Daniel Freeman, Bryony Sheaves, Felicity Waite, et al.
The Lancet Psychiatry (2020) Vol. 7, Iss. 7, pp. 628-637
Closed Access | Times Cited: 505
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Stefano Aringhieri, Marco Carli, Shivakumar Kolachalam, et al.
Pharmacology & Therapeutics (2018) Vol. 192, pp. 20-41
Closed Access | Times Cited: 177
Pharmacopsychiatry

Pharmacopsychiatry (2025)
Closed Access | Times Cited: 6
The trajectory of sedative adverse events caused by antipsychotics: a meta-analysis of individual participant data from randomised, placebo-controlled, clinical trials in acute phase schizophrenia
Nobuyuki Nomura, Spyridon Siafis, Johannes Schneider‐Thoma, et al.
The Lancet Psychiatry (2025) Vol. 12, Iss. 4, pp. 266-275
Open Access | Times Cited: 2
Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108236-108236
Open Access | Times Cited: 48
Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia
Kazunari Yoshida, Hiroyoshi Takeuchi
Behavioural Brain Research (2021) Vol. 402, pp. 113098-113098
Open Access | Times Cited: 54
Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
Paula Soria‐Chacartegui, Gonzalo Villapalos‐García, Pablo Zubiaur, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
Calcium-mediated one-pot preparation of isoxazoles with deuterium incorporation
Maria S. Ledovskaya, Konstantin S. Rodygin, Valentine P. Ananikov
Organic Chemistry Frontiers (2017) Vol. 5, Iss. 2, pp. 226-231
Open Access | Times Cited: 53
Antipsychotics and sedation: from clinical to shared decision making
Subho Chakrabarti
The Lancet Psychiatry (2025) Vol. 12, Iss. 4, pp. 241-243
Closed Access
Antipsychotic medications and sleep problems in patients with schizophrenia
Erik Cederlöf, Minna Torniainen‐Holm, Heidi Taipale, et al.
Schizophrenia Research (2024) Vol. 267, pp. 230-238
Open Access | Times Cited: 4
Digital sleep phenotype and wrist actigraphy in individuals at clinical high risk for psychosis and people with schizophrenia spectrum disorders: a systematic review and meta-analysis
Rosario Aronica, Edoardo G. Ostinelli, Charlotte Austin, et al.
BMJ Mental Health (2025) Vol. 28, Iss. 1, pp. e301337-e301337
Open Access
Childhood trauma, depression, and sleep quality and their association with psychotic symptoms and suicidality in schizophrenia
Esin Evren Kılıçaslan, A. Esen, Meltem I. Kasal, et al.
Psychiatry Research (2017) Vol. 258, pp. 557-564
Closed Access | Times Cited: 35
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews
Michele Fornaro, Domenico De Berardis, Giampaolo Perna, et al.
BioMed Research International (2017) Vol. 2017, pp. 1-17
Open Access | Times Cited: 34
Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004–2020
Eugene A. Kiyatkin, Beata Eugene, Marek Masiak, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 23
State-of-the-art pharmacological approaches to reduce chorea in Huntington’s disease
Jessie S. Gibson, Daniel O. Claassen
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 8, pp. 1015-1024
Open Access | Times Cited: 22
Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis
Yarmila Elena Valencia Carlo, Ricardo Saracco-Álvarez, V. Carlo, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 8
Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
Andrea de Bartolomeis, Mariateresa Ciccarelli, Giuseppe De Simone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5945-5945
Open Access | Times Cited: 7
Poor sleep quality in schizophrenia patients: A systematic review and meta-analyses of epidemiological and case-control studies
Meng-Yi Chen, Yueying Wang, Tong Leong, et al.
Schizophrenia Research (2024) Vol. 264, pp. 407-415
Closed Access | Times Cited: 2
Prevalence and factors associated with fatigue in patients with major depressive disorder or bipolar disorder
Keming Gao, Joseph R. Calabrese
Journal of Affective Disorders (2024) Vol. 362, pp. 493-501
Closed Access | Times Cited: 2
Validation of the xylazine/ketamine anesthesia test as a predictor of the emetic potential of pharmacological compounds in rats
Ellis Nelissen, Nick P. van Goethem, Vivian Taciany Bonassoli, et al.
Neuroscience Letters (2019) Vol. 699, pp. 41-46
Open Access | Times Cited: 20
Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review
Luyao Cai, Guanjie Chen, Haichen Yang, et al.
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 4, pp. 249-260
Closed Access | Times Cited: 6
Systematic Analysis of Protein Targets Associated with Adverse Events of Drugs from Clinical Trials and Postmarketing Reports
Ines Smit, Avid M. Afzal, Chad H. G. Allen, et al.
Chemical Research in Toxicology (2020) Vol. 34, Iss. 2, pp. 365-384
Open Access | Times Cited: 17
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years
Yu Hong, Wenbo Huang, Dai-Yin Cao, et al.
Psychopharmacology (2022) Vol. 239, Iss. 10, pp. 3367-3375
Closed Access | Times Cited: 10
A Pilot Study of the Effectiveness of Lithium Versus Quetiapine Immediate Release Monotherapy in Patients With Bipolar Spectrum Disorders
Keming Gao, Toyomi Goto, Chengmei Yuan, et al.
Journal of Clinical Psychopharmacology (2018) Vol. 38, Iss. 5, pp. 422-434
Closed Access | Times Cited: 18
Acceptability of Acute and Maintenance Pharmacotherapy of Bipolar Disorder
Yuanhan Bai, Haichen Yang, Guanjie Chen, et al.
Journal of Clinical Psychopharmacology (2020) Vol. 40, Iss. 2, pp. 167-179
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top